Immune surveillance in multiple sclerosis patients treated with natalizumab. Stüve O, Marra CM, Jerome KR, Cook L, Cravens PD, Cepok S, Frohman EM, Phillips TJ, Arendt G, Hemmer B, et al. Ann Neurol. 2006 May; 59(5):743-7. PMID: 16634029. Abstract CommentRecommendBookmarkWatch